Delivery Order SPE2DB22D9316-SPE2DB24FYP53

Award Date 6/24/24
Potential Completion Date 7/16/24
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $27,688.80, is for the delivery of Botox 100 unit vials. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC covers a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $23,074.00, is to provide 100-unit vials of the drug Botox. The delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which allows the DLA to issue delivery orders for a wide range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,075.52 order is for the supply of Botox 100 unit vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,171.25 contract is for the delivery of Botox 200 unit vials to fulfill the recurring medical supply needs of military health facilities. The delivery order was issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,459.20 contract is for the delivery of Botox 100 unit vials to support the medical supply needs of military healthcare facilities. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) awarded to DMS Pharmaceutical Group Inc. under the DLA's...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $16,613.28, is for the supply of 100-unit vials of Botox to support the recurring medical supply needs of military health facilities. The delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that allows the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $91,360.00 firm fixed-price contract is for the supply of 100-unit vials of BOTOX to support the recurring medical supply needs of military health facilities worldwide. The delivery order is part of a larger indefinite delivery contract (IDC) worth up to $499,999,999 that DMS Pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $5,537.76 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Botox 100 unit vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,844.40, is for the delivery of 100-unit vials of Botox to fulfill the recurring medical supply needs of military health facilities worldwide. The contract is part of DMS Pharmaceutical Group's broader $499,999,999 indefinite delivery contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $34,611.00, is for the delivery of BOTOX 100 unit vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the...
  • SPE2DB22D9316
    Indefinite Delivery Contract
  • SPE2DB22D9316-SPE2DB24FYP53
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $23,074.00, is for the delivery of Botox (100 unit vials) to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to DMS Pharmaceutical Group by the DLA under the SPE2DB program, which has a ceiling value of up to $499,999,999 and runs through December 31, 2025. Through this IDC, DMS Pharmaceutical Group provides a wide range of pharmaceutical products, including both common and specialized medications, to support the diverse medical requirements of the Department of Defense (DoD) healthcare system. This contract does not have a set-aside designation.

Generated 9/23/24, 10:02 AM